Read more about the result of Epitalon peptide therapy on our dedicated Epithalon page
Congdon EE, Ji C, Tetlow AM (2023) Tau-targeting therapies for Alzheimer disease: current status and future directions
We monitor patients regularly and adjust protocols based on response
This was achieved by demethylating the promoters of 14-3-3, CHK2 and DAPK-1 genes, promoting the expression of these genes, and then activating the G2/M checkpoint response in osteosarcoma cells, to improve the radiotherapy effect of osteosarcoma 10 (Figure 1 and Table 1)
Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells
The simplest way to picture it: GLP-1 tells your gut to slow down, while amylin tells your brain you are full - through a different channel